TAMBOCOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tambocor, and when can generic versions of Tambocor launch?
Tambocor is a drug marketed by Alvogen and is included in one NDA.
The generic ingredient in TAMBOCOR is flecainide acetate. There are ten drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the flecainide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tambocor
A generic version of TAMBOCOR was approved as flecainide acetate by AMNEAL PHARM on July 31st, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TAMBOCOR?
- What are the global sales for TAMBOCOR?
- What is Average Wholesale Price for TAMBOCOR?
Summary for TAMBOCOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 169 |
| Clinical Trials: | 7 |
| Patent Applications: | 3,987 |
| Drug Prices: | Drug price information for TAMBOCOR |
| DailyMed Link: | TAMBOCOR at DailyMed |
Recent Clinical Trials for TAMBOCOR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wojciech Zareba | Phase 2 |
| Keimyung University Dongsan Medical Center | Phase 4 |
| Chong Kun Dang Pharmaceutical Corp. | Phase 4 |
US Patents and Regulatory Information for TAMBOCOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-004 | Aug 23, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-002 | Oct 31, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-001 | Oct 31, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-003 | Jun 3, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TAMBOCOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-002 | Oct 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-004 | Aug 23, 1988 | ⤷ Sign Up | ⤷ Sign Up |
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-001 | Oct 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-001 | Oct 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-003 | Jun 3, 1988 | ⤷ Sign Up | ⤷ Sign Up |
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-003 | Jun 3, 1988 | ⤷ Sign Up | ⤷ Sign Up |
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-003 | Jun 3, 1988 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TAMBOCOR
See the table below for patents covering TAMBOCOR around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Spain | 489629 | ⤷ Sign Up | |
| Switzerland | 643829 | VERFAHREN ZUR HERSTELLUNG VON 2,5-BIS(2,2,2-TRIFLUORAETHOXY)-N-(2-PIPERIDYLMETHYL)BENZAMID. | ⤷ Sign Up |
| United Kingdom | 1411518 | ⤷ Sign Up | |
| Denmark | 158980 | ⤷ Sign Up | |
| Japan | H01125339 | PRODUCTION OF 1, 4-BIS (2, 2, 2- TRIFLUOROETHOXY)BENZENE | ⤷ Sign Up |
| Canada | 1137486 | METHODE DE PREPARATION DE 2,5-BIS(2,2,2,- TRIFLUOROETHOXY)-N-(2-PIPERIDYLMETHYL) BENZAMIDE (PROCESS FOR THE PREPARATION OF 2,5-BIS(2,2,2- TRIFLUOROETHOXY)-N-(2-PIPERIDYLMETHYL) BENZAMIDEE) | ⤷ Sign Up |
| Ireland | 800549 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
